ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 142 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,095,000 | -14.5% | 153,799 | +99.3% | 0.00% | 0.0% |
Q2 2021 | $1,281,000 | -17.2% | 77,177 | -29.2% | 0.00% | 0.0% |
Q1 2021 | $1,548,000 | +561.5% | 109,065 | +829.2% | 0.00% | – |
Q4 2020 | $234,000 | +397.9% | 11,738 | +249.6% | 0.00% | – |
Q3 2020 | $47,000 | -32.9% | 3,358 | -27.0% | 0.00% | – |
Q2 2020 | $70,000 | -61.7% | 4,597 | -58.5% | 0.00% | – |
Q4 2019 | $183,000 | +41.9% | 11,090 | +21.8% | 0.00% | – |
Q3 2019 | $129,000 | -22.8% | 9,107 | +9.5% | 0.00% | – |
Q2 2019 | $167,000 | -8.2% | 8,314 | +81.1% | 0.00% | – |
Q1 2019 | $182,000 | +1.1% | 4,591 | -11.4% | 0.00% | – |
Q4 2018 | $180,000 | -10.9% | 5,183 | +6.2% | 0.00% | – |
Q3 2018 | $202,000 | +12.2% | 4,881 | +0.0% | 0.00% | – |
Q2 2018 | $180,000 | +0.6% | 4,880 | +6.3% | 0.00% | – |
Q1 2018 | $179,000 | +115.7% | 4,591 | 0.0% | 0.00% | – |
Q4 2017 | $83,000 | +9.2% | 4,591 | 0.0% | 0.00% | – |
Q3 2017 | $76,000 | -90.9% | 4,591 | -92.3% | 0.00% | -100.0% |
Q2 2017 | $834,000 | +5460.0% | 59,591 | +7367.5% | 0.00% | – |
Q1 2016 | $15,000 | – | 798 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
Baupost Group | 8,123,616 | $26,645 | 0.44% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |